BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11321869)

  • 1. Nalidixic acid is still the drug of choice for shigellosis in Pakistan.
    Mahmood A
    J Pak Med Assoc; 2001 Feb; 51(2):101. PubMed ID: 11321869
    [No Abstract]   [Full Text] [Related]  

  • 2. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy.
    Cheasty T; Day M; Threlfall EJ
    Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of furazolidone and nalidixic acid in the empirical treatment of acute invasive diarrhea: randomized clinical trial.
    Dutta P; Sett A; Sarkar A; Mitra U; Saha D; Manna B; Kundu B; Gupta A
    Indian Pediatr; 1995 Jan; 32(1):13-9. PubMed ID: 8617528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shigella isolation in Vellore, south India (1997-2001).
    Jesudason MV
    Indian J Med Res; 2002 Jan; 115():11-3. PubMed ID: 12424931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nalidixic acid-resistant Shigella dysenteriae type I in KwaZulu-Natal.
    Karas JA; Pillay DG
    S Afr Med J; 1996 Jan; 86(1):93. PubMed ID: 8685796
    [No Abstract]   [Full Text] [Related]  

  • 6. International note. Antibiotics in the management of shigellosis.
    Can Commun Dis Rep; 2004 Dec; 30(23):202-3. PubMed ID: 15603533
    [No Abstract]   [Full Text] [Related]  

  • 7. Serogroup prevalence of Shigellae in Bombay.
    Sonawala M; Saraswathi K; Deodhar LP
    J Postgrad Med; 1995; 41(4):104-6. PubMed ID: 10707731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis.
    Haltalin KC; Nelson JD; Kusmiesz HT
    Arch Dis Child; 1973 Apr; 48(4):305-12. PubMed ID: 4574641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical study of wintomylon in the treatment of shigellosis.
    Yu PC; Chen HS
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1965; 6(3):127-31. PubMed ID: 5861506
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combined therapy of methacolimycin (sodium colistin methanesulfonate) and Wintomylon (nalidixic acid) in bacillary dysentery].
    Tajime H; Hirayama A; Takayama Y; Imagawa Y
    Nihon Densenbyo Gakkai Zasshi; 1968 Mar; 41(12):445-9. PubMed ID: 4971073
    [No Abstract]   [Full Text] [Related]  

  • 11. Changing patterns of serotypes and antimicrobial susceptibilities of Shigella species isolated from children in Calcutta, India.
    Niyogi SK; Mitra U; Dutta P
    Jpn J Infect Dis; 2001 Jun; 54(3):121-2. PubMed ID: 11544405
    [No Abstract]   [Full Text] [Related]  

  • 12. Nalidixic acid in Shigella dysenteriae outbreaks.
    Malengreau M
    Lancet; 1984 Jul; 2(8395):172. PubMed ID: 6146074
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid.
    Vinh H; Wain J; Chinh MT; Tam CT; Trang PT; Nga D; Echeverria P; Diep TS; White NJ; Parry CM
    Trans R Soc Trop Med Hyg; 2000; 94(3):323-6. PubMed ID: 10975012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nalidixic-acid-resistant Shigella dysenteriae I.
    Panhotra BR; Desai B; Sharma PL
    Lancet; 1985 Mar; 1(8431):763. PubMed ID: 2858035
    [No Abstract]   [Full Text] [Related]  

  • 15. Controlled comparison of nalidixic acid or lactulose with placebo in shigellosis.
    Hansson HB; Barkenius G; Cronberg S; Juhlin I
    Scand J Infect Dis; 1981; 13(3):191-3. PubMed ID: 7031858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of bacillary dysentery with Wintomylon].
    Ishikawa J
    Nihon Densenbyo Gakkai Zasshi; 1967 Mar; 40(12):460-2. PubMed ID: 4962909
    [No Abstract]   [Full Text] [Related]  

  • 17. Nalidixic-acid resistant Shigella dysenteriae type 1 in eastern India.
    Sen D; Dutta P; Deb BC; Pal SC
    Lancet; 1988 Oct; 2(8616):911. PubMed ID: 2902361
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemic dysentery caused by Shigella dysenteriae type 1: a sentinel site surveillance of antimicrobial resistance patterns in Burundi.
    Engels D; Madaras T; Nyandwi S; Murray J
    Bull World Health Organ; 1995; 73(6):787-91. PubMed ID: 8907772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of nalidixic acid resistance in Shigella sonnei isolated from patients having acute diarrheal disease: report from eastern province of Saudi Arabia.
    Panhotra BR; Saxena AK; Al-Mulhim K
    Jpn J Infect Dis; 2004 Jun; 57(3):116-8. PubMed ID: 15218222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of health services utilization on the recovery from dysentery.
    Myaux JA; Chakraborty J; Yunus M; Khan EH; de Francisco A
    J Trop Pediatr; 1996 Feb; 42(1):38-42. PubMed ID: 8820619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.